727 related articles for article (PubMed ID: 26497471)
21. A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.
Caillard S; Cellot E; Dantal J; Thaunat O; Provot F; Janbon B; Buchler M; Anglicheau D; Merville P; Lang P; Frimat L; Colosio C; Alamartine E; Kamar N; Heng AE; Durrbach A; Moal V; Rivalan J; Etienne I; Peraldi MN; Moreau A; Moulin B;
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1663-1670. PubMed ID: 28818847
[TBL] [Abstract][Full Text] [Related]
22. Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipients.
Zierhut H; Kanzelmeyer N; Buescher A; Höcker B; Mauz-Körholz C; Tönshoff B; Metzler M; Pohl M; Pape L; Maecker-Kolhoff B
Pediatr Transplant; 2021 Sep; 25(6):e14042. PubMed ID: 34021949
[TBL] [Abstract][Full Text] [Related]
23. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
[TBL] [Abstract][Full Text] [Related]
24. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
[TBL] [Abstract][Full Text] [Related]
25. Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease.
Weiner C; Weintraub L; Wistinghausen B; Tomaino J; Arnon R; Kerkar N; Miloh T
Pediatr Transplant; 2012 Aug; 16(5):458-64. PubMed ID: 22554096
[TBL] [Abstract][Full Text] [Related]
26. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
27. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
Shapiro R; Nalesnik M; McCauley J; Fedorek S; Jordan ML; Scantlebury VP; Jain A; Vivas C; Ellis D; Lombardozzi-Lane S; Randhawa P; Johnston J; Hakala TR; Simmons RL; Fung JJ; Starzl TE
Transplantation; 1999 Dec; 68(12):1851-4. PubMed ID: 10628763
[TBL] [Abstract][Full Text] [Related]
28. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ
Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
[TBL] [Abstract][Full Text] [Related]
29. Retransplantation after post transplant lymphoproliferative disorder: overcoming the obstacles!
Prasad P; Khullar D; Gupta N; Grover R; Chhabra G; Gandhi KR; Gupta S; Bagai S
CEN Case Rep; 2020 Aug; 9(3):200-203. PubMed ID: 32016786
[TBL] [Abstract][Full Text] [Related]
30. Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation.
Kew CE; Lopez-Ben R; Smith JK; Robbin ML; Cook WJ; Gaston RS; Deierhoi MH; Julian BA
Transplantation; 2000 Mar; 69(5):809-14. PubMed ID: 10755531
[TBL] [Abstract][Full Text] [Related]
31. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
Newell KA; Alonso EM; Whitington PF; Bruce DS; Millis JM; Piper JB; Woodle ES; Kelly SM; Koeppen H; Hart J; Rubin CM; Thistlethwaite JR
Transplantation; 1996 Aug; 62(3):370-5. PubMed ID: 8779685
[TBL] [Abstract][Full Text] [Related]
32. Rational management of posttransplant lymphoproliferative disorder in pediatric recipients.
Praghakaran K; Wise B; Chen A; Schwarz K; Colombani P
J Pediatr Surg; 1999 Jan; 34(1):112-5; discussion 115-6. PubMed ID: 10022154
[TBL] [Abstract][Full Text] [Related]
33. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
34. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
Raj R; Frost AE
J Heart Lung Transplant; 2005 Jun; 24(6):671-9. PubMed ID: 15949726
[TBL] [Abstract][Full Text] [Related]
35. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
Cacciarelli TV; Green M; Jaffe R; Mazariegos GV; Jain A; Fung JJ; Reyes J
Transplantation; 1998 Oct; 66(8):1047-52. PubMed ID: 9808490
[TBL] [Abstract][Full Text] [Related]
36. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
Gross TG; Bucuvalas JC; Park JR; Greiner TC; Hinrich SH; Kaufman SS; Langnas AN; McDonald RA; Ryckman FC; Shaw BW; Sudan DL; Lynch JC
J Clin Oncol; 2005 Sep; 23(27):6481-8. PubMed ID: 16170157
[TBL] [Abstract][Full Text] [Related]
37. Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients.
Soler MJ; Puig JM; Mir M; Parrilla J; Pedro C; Salar A; Serrano S; Lloveras J
Transplant Proc; 2003 Aug; 35(5):1709-13. PubMed ID: 12962767
[TBL] [Abstract][Full Text] [Related]
38. Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.
Wudhikarn K; Holman CJ; Linan M; Blaes AH; Dunitz JM; Hertz ME; Peterson BA
Clin Transplant; 2011; 25(5):705-13. PubMed ID: 21077949
[TBL] [Abstract][Full Text] [Related]
39. Thoracic presentations of posttransplant lymphoproliferative disorders.
Halkos ME; Miller JI; Mann KP; Miller DL; Gal AA
Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707
[TBL] [Abstract][Full Text] [Related]
40. An approach to finding indications and contraindications for nephrectomy in post-transplant renal graft lymphomas: PTLD.Int survey.
Gholipour-Shoiili A; Gholipour-Shoiili H; Taheri S
Hematol Oncol Stem Cell Ther; 2011; 4(4):167-72. PubMed ID: 22198192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]